Fig. 6From: Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label studyPCT as a function of arterolane exposure (AUC last)Back to article page